Search Results

Three-Year Data From ANCHOR Registry Presented for Medtronic's Heli-FX EndoAnchor System

November 16, 2018—Medtronic announced the presentation of data on the Heli-FX EndoAnchor system by William Jordan Jr, MD, at the 45th annual VEITHsymposium held November 13–17 in New York, New York.

Gore's TAG Conformable Thoracic Stent Graft With Active Control System Launched in the United States

July 10, 2019—Gore & Associates announced the commercial launch in the United States of the company's TAG conformable thoracic stent graft with Active Control system, with the first implantation of the device performed by William Jordan, MD, from Emory University School of Medicine in Atlanta, Georgia.

Conformable Gore TAG Device Used in IDE Trial

October 20, 2009—W.

First Implants Performed in Trial of Next-Generation Conformable Gore TAG Device

October 20, 2009—W.L.

Endologix ChEVAS System Receives FDA Breakthrough Device Designation

July 19, 2021—Endologix LLC announced that the company’s chimney endovascular aneurysm sealing (ChEVAS) system, has been granted a Breakthrough Device designation from the FDA.

FDA Approves Indication for Medtronic Endurant II/IIs Stent Graft System to Treat Short-Neck Anatomies

October 9, 2017—Medtronic announced that it has received US Food and Drug Administration (FDA) approval for the Endurant II/IIs stent graft system to treat abdominal aortic aneurysm (AAA) patients with neck lengths down to 4 mm and ≤ 60° infrarenal angulation when used in combination with the Heli-FX EndoAnchor system.

FDA Approves Conformable Gore TAG Thoracic Endoprosthesis

November 16, 2011—Gore & Associates (Flagstaff, AZ) announced that it has received approval from the US Food and Drug Administration to market the Conformable Gore TAG thoracic endoprosthesis as a minimally invasive treatment of thoracic aortic aneurysms.

Medtronic's Endurant II/IIs System With Heli-FX EndoAnchor System Granted CE Mark Approval for Indication to Treat Short-Neck Anatomies

December 12, 2017—Medtronic announced that it has received European CE Mark approval for its Endurant II/IIs stent graft system to treat abdominal aortic aneurysm patients with neck lengths as small as 4 mm and ≤ 60° infrarenal angulation when used in combination with the Heli-FX EndoAnchor system.

Medtronic Presents 1-Year Valiant Navion and 4-Year ANCHOR Registry Outcomes

November 22, 2019—Medtronic announced the presentation of 1-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and 4-year clinical outcomes from the ANCHOR registry evaluating the company’s Heli-FX EndoAnchor system in patients with hostile neck abdominal aortic aneurysms (AAAs) at the VEITHsymposium held November 19–23 in New York, New York.

ANCHOR Postmarket Registry Will Evaluate Aptus' HeliFX

February 14, 2012—Aptus Endosystems, Inc. (Sunnyvale, CA) announced the start of the ANCHOR postmarket registry, which will evaluate the use of the company's HeliFX aortic securement system.

ANCHOR Postmarket Registry Will Evaluate Aptus' HeliFX

February 14, 2012—Aptus Endosystems, Inc. (Sunnyvale, CA) announced the start of the ANCHOR postmarket registry, which will evaluate the use of the company's HeliFX aortic securement system.

Three-Year Clinical Data Presented for Endurant AAA Stent Graft

May 31, 2013—New data on the Endurant abdominal aortic aneurysm (AAA) stent graft system (Medtronic, Inc., Minneapolis, MN) were presented at the Society for Vascular Surgery's Vascular Annual Meeting being held in San Francisco, California.

Medtronic's Heli-FX EndoAnchor System Yields Positive Results for Patients With Hostile Aortic Neck Anatomy

November 17, 2016—Medtronic announced a series of new data on its Heli-FX EndoAnchor system that show enhanced outcomes and durability in patients with complex aortic abdominal aneurysm (AAA) anatomy, particularly those who have hostile aortic neck anatomy.